Agresta Samuel
Insider CIK 1748961 · INFI Chief Medical Officer, Director · OKUR Chief Medical Officer · FHTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | $0 | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | $0 | 18,588 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | $0 | 131,396 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | — | 131,396 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 131,396 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | — | 18,588 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | D To issuer deriv | 2026-08-07 | 2026-08-11 | 18,588 | — | — | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-04-01 | 2026-04-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-01-27 | 2025-01-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 18,588 | — | $0 | 18,588 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 131,396 | — | $0 | 131,396 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 311,297 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | S Sale | 2023-08-16 | 2023-08-18 | 311,297 | $8.25 | $2.57M | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise | 2023-08-16 | 2023-08-18 | 311,297 | $3.72 | $1.16M | 311,297 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 60,000 | — | $0 | 60,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-01-26 | 2022-01-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2021-06-10 | 2021-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-01-28 | 2021-02-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2020-10-16 | 2019-10-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2019-01-04 | 2019-01-07 | 62,596 | — | $0 | 62,596 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-08-06 | 2018-08-07 | 300,000 | — | $0 | 300,000 | SEC↗ |